| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | Mar 20, 2025 | CytomX Therapeutics, Inc. | Chief Medical Officer | Sell | 47.5 | -4,025 | -2.88% | ✗ | $2.4K |
| Apr 18, 2023 | Apr 19, 2023 | FATE THERAPEUTICS INC | Chief Medical Officer | Sell | 46.3 | -2,532 | -1.77% | ✗ | $16.6K |
| Jan 10, 2023 | Jan 11, 2023 | FATE THERAPEUTICS INC | Chief Medical Officer | Sell | 46.3 | -7,825 | -5.18% | ✗ | $41K |
| Apr 19, 2022 | Apr 21, 2022 | FATE THERAPEUTICS INC | Chief Medical Officer | Sell | 42.5 | -4,062 | -2.62% | ✗ | $143.7K |
| Jan 11, 2022 | Jan 13, 2022 | FATE THERAPEUTICS INC | Senior VP Clinical Development | Sell | 42.5 | -3,965 | -3.15% | ✗ | $192.3K |
| Dec 10, 2021 | Dec 13, 2021 | FATE THERAPEUTICS INC | Senior VP Clinical Development | Sell | 45.0 | -7,500 | -0.83% | ✓ | $385.9K |
| Apr 16, 2021 | Apr 20, 2021 | FATE THERAPEUTICS INC | Senior VP Clinical Development | Sell | 40.0 | -3,275 | -4.81% | ✗ | $272.8K |